Bilateral project Slovenia-Brasil 2012-2014
»Development and use of aptamer analytical tools for tumor diagnostics based on circulation of tumor (stem) cells in blood«
The project's aim is to research and develop analytical and preparative tools for tumor cell diagnostics. BILAB's role in the project is to develop aptamers selective for circulating tumor (stem) cells which will be useful for the development of preparative and diagnostic tools.
The project is a cooperation between:
- Sao Paulo University, Brasil
- National institute of biology (NIB)
European regional development fund's Project Mina
»Environmental pollutants and neurodegenerative illnesses - a multidisciplinary study based on research and innovativity« in the framework of the European cross-border cooperation Italy-Slovenia 2007-2013.
The goal of the project is to support research and create synergies between research institutions in the field of biomedical studies and neurodegenerative illnesses. The project is focused on creating a new network of highly skilled staff that will have an improved access to joined infrastructure. Furthermore the researchers shall enjoy an enhanced mobility environment and the availability of new research themes that have considerable impact on social and health aspects of neurodegenerative illnesses. The support goes along the lines of research and development of biomedical technologies which could be used for the economic development of the region and could carry stimulus for more competitive businesses.
BILAB's role in the project:
- Research in the field of aptamer based biosensors for detection of adenosine triphosphate (ATP) and other soluble mediators that are important in neurological studies.
- Italy: International School for Advanced Studies (SISA), University of Udine
- Slovenija: Cobik, University of Nova Gorica
»Cross-border study of proteins for oncologic research and diagnosics« is a European regional development fund's project in the framework of the European cross-border cooperation Italy-Slovenia 2007-2013.
The project proposes setting up a center for automated production of recombinant proteins by means of cooperation between research institutions and small and medium businesses in Italy and Slovenia. The Center will be focused on a set of research project on general and applicative oncology. In the long run, the center will offer innovative, high-tech services. It will be open for the needs of academic and industrial researchers from biomedical, pharmaceutical and environmental scientific branches and will increase productivity and competitiveness. The synergy based on private-public partnership will enable to establish a training program on biotechnological and biomedical fields. The training will give rise to interdisciplinary and inter-sectorial knowledge.
BILAB's role in the project:
- Development of aptamers, aptamer markers and bio-receptors for bio-analytical applications for cancer research.
- Italy: Sincrotrone Trieste S.C.p.A., Interuniversity Consortium for Biotechnology (CIB) University of Udine.
The goal of PACiNNO is to establish a platform for cooperation in research and innovation covering the whole Adriatic region. Targeting both research institutions, policy makers and business entities, the project will help develop new bridges between the research and scientific activities, carried out at academic institutions, and the economic system, with specific reference to the technological needs of SMEs. More generally, PACiNNO is aimed at overcoming the main obstacles and barriers to the economic development of the Adriatic countries, fostering the competitiveness of their minor firms (both in the high-tech fields and in the traditional industries), and promoting the creation of innovative start-ups.
To reach such ambitious goals, the project will capitalize on the several programs and initiatives already implemented in the Adriatic region by the EU, the national governments and the local stakeholders. PACiNNO will combine research activities with direct interventions in the local innovation systems.
The active involvement and participation to the project initiative of the key innovation stakeholders (research centres, territorial bodies, science and technology parks, business incubators, financial investors, business units, multinational companies based in the region) is meant to create a regional innovation system supported by a permanent platform of collaboration, where private and public institutions can interact and integrate their efforts and resources to favor innovation outcomes across the region, even after the end of PACiNNO.
IPCOS – Imprinted Polymers as Coffee Sensors
The IPCOS project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Actions (MSCA) - Innovative Training Networks (ITN) under the grant agreement number 642014.
The aim of the IPCOS Network is to bring innovation to the field of food quality by offering an international, interdisciplinary and intersectorial doctoral training programme that will target the development of chemical sensors, using the molecular imprinting technology, for application in the coffee industry, focusing on three main groups of targets: a) chlorogenic acids, b) cafestol and kaurene terpenes, c) caffeine
This project brings together 2 academic teams, 1 large international company, 1 SME and one non-profit research centre of excellence, supported by 4 associated teams, with a very multidisciplinary and multisectorial expertise. The IPCOS training programme will require ESRs to work 50% of their time in industry, providing them with a set of unique scientific and transferable skills that will match both public and private sector needs, together with a strong development of innovation and entrepreneurship ethos, therefore considerably enhancing their career perspectives. All researchers will aim to achieve a doctoral degree at the end of their training. As a result of the close collaborative links, IPCOS will strengthen the innovation capacity of universities/research institutes to commercially exploit their research and enhance the research potential and competitiveness of European companies and SMEs.